Reliability, Safety, and Performance in HDR Brachytherapy


After extensive market research in cooperation with brachytherapy physicians, medical physics, safety and usability experts, Eckert & Ziegler BEBIG defined the next generation in HDR brachytherapy: SagiNova® offers an unmatched ability to perform optimal brachytherapy treatments with seamless software integration. Eckert & Ziegler BEBIG exclusively provides the unique choice of two isotopes, Ir-192 and Co-60. Both sources are equivalent in size and have been in clinical use for more than 10 years. The unique In-Vivo Dosimetry System allows direct independent monitoring of doses to rectum and bladder at the control console alongside treatment information. Dose limit values can be defined via the SagiNova® treatment control software and warnings are displayed if bladder or rectum dose limits are exceeded. The highly customizable tool QAssist supports physicists by defining and running site specific quality assurance protocols. Guiding the performance of these protocols, QAssist ensures streamlined and well documented quality assurance. By choosing an applicator in SagiPlan®, the length of the applicator and the overall length of the application are digitally transferred to the afterloader without requiring any manual input. Hence, the afterloader is able to validate the correct overall length per channel prior to each source movement. SagiNova® measures the internal length of the catheter or applicator allowing the user to review and complete acceptance while the unit completes a verification of the length before the treatment is delivered. 

For additional information, please see or:

Brochure SagiNova® (USA)

Fact sheet In-Vivo Dosimetry for SagiNova® (USA)

Fact sheet Co-60 in HDR Brachytherapy (USA)

DICOM Conformance Statement (EN)